These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 10367099

  • 1. Placebo--efficacy and adverse effects in controlled clinical trials.
    Weihrauch TR, Gauler TC.
    Arzneimittelforschung; 1999 May; 49(5):385-93. PubMed ID: 10367099
    [Abstract] [Full Text] [Related]

  • 2. [Placebo effects and adverse effects in clinical trials].
    Weihrauch TR.
    Med Klin (Munich); 2000 May; 95(1 Spec No):23-30. PubMed ID: 10851845
    [Abstract] [Full Text] [Related]

  • 3. [Placebo effect in clinical trials].
    Weihrauch TR.
    Med Klin (Munich); 1999 Mar 15; 94(3):173-81. PubMed ID: 10218354
    [Abstract] [Full Text] [Related]

  • 4. Placebo treatment is effective differently in different diseases--but is it also harmless? A brief synopsis.
    Weihrauch TR.
    Sci Eng Ethics; 2004 Jan 15; 10(1):151-5. PubMed ID: 14986781
    [Abstract] [Full Text] [Related]

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jan 15; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995 Jan 15; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 7. [Controlled randomized clinical trials].
    Jaillon P.
    Bull Acad Natl Med; 2007 Jan 15; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [Abstract] [Full Text] [Related]

  • 8. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M.
    J Bone Miner Res; 2003 Jun 15; 18(6):1142-5. PubMed ID: 12817772
    [Abstract] [Full Text] [Related]

  • 9. [The limits of controlled clinical studies: the case of rheumatology].
    Portioli I.
    Ann Ital Med Int; 2000 Jun 15; 15(1):39-46. PubMed ID: 10842890
    [Abstract] [Full Text] [Related]

  • 10. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.
    J Clin Psychiatry; 2011 Apr 15; 72(4):464-72. PubMed ID: 21527123
    [Abstract] [Full Text] [Related]

  • 11. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E, PISA (Persantin In Stable Angina) study group.
    Eur Heart J; 2001 Oct 15; 22(19):1785-93. PubMed ID: 11549300
    [Abstract] [Full Text] [Related]

  • 12. Confirming false adverse reactions to drugs by performing individualized, randomized trials.
    Knowles SR, Uetrecht JP, Shear NH.
    Can J Clin Pharmacol; 2002 Oct 15; 9(3):149-53. PubMed ID: 12422252
    [Abstract] [Full Text] [Related]

  • 13. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects.
    Rief W, Avorn J, Barsky AJ.
    Arch Intern Med; 2006 Jan 23; 166(2):155-60. PubMed ID: 16432082
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 23; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 15. Placebo, a historical perspective.
    Czerniak E, Davidson M.
    Eur Neuropsychopharmacol; 2012 Nov 23; 22(11):770-4. PubMed ID: 22608298
    [Abstract] [Full Text] [Related]

  • 16. Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research.
    Olfson M, Marcus SC.
    Health Aff (Millwood); 2013 Jun 23; 32(6):1116-25. PubMed ID: 23733987
    [Abstract] [Full Text] [Related]

  • 17. Randomized placebo-controlled cross-over designs in clinical trials: a gold standard to be reassessed.
    Leonard G, Lafrenaye S, Goffaux P.
    Curr Med Res Opin; 2012 Feb 23; 28(2):245-8. PubMed ID: 22208674
    [Abstract] [Full Text] [Related]

  • 18. Placebo effect in child and adolescent psychiatric trials.
    Parellada M, Moreno C, Moreno M, Espliego A, de Portugal E, Arango C.
    Eur Neuropsychopharmacol; 2012 Nov 23; 22(11):787-99. PubMed ID: 22030230
    [Abstract] [Full Text] [Related]

  • 19. Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials.
    Mahr A, Golmard C, Pham E, Iordache L, Deville L, Faure P.
    Pharmacoepidemiol Drug Saf; 2017 Jul 23; 26(7):731-741. PubMed ID: 28176407
    [Abstract] [Full Text] [Related]

  • 20. Active placebo control groups of pharmacological interventions were rarely used but merited serious consideration: a methodological overview.
    Jensen JS, Bielefeldt AØ, Hróbjartsson A.
    J Clin Epidemiol; 2017 Jul 23; 87():35-46. PubMed ID: 28342907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.